Home » Research » Innovation Award
This award will be
|
2012 Diabetes Research Innovation Award
JDRF and the Macquarie Group Foundation continue their support of excellence and innovation in type 1 diabetes research in 2012, through the annual Diabetes Research Innovation Awards.
The Awards will be presented to outstanding researchers in the field of type 1 diabetes for the publications or patents demonstrating the highest innovation, impact and importance in the 2011 calendar year.
Awards are offered in two categories: Early Career Researcher and Established Researcher. The winners of each Award receive a personal award and a cash prize of $5,000, to be used for the advancement of their research career in the field of type 1 diabetes.
Eligibility
The research submitted for review is to have been conducted in Australia.
Applicants must be appropriately qualified (PhD, MB BS or equivalent). If the relevant qualifications were earned within 15 years prior to submission of the application, the applicant is eligible for the Early Career Researcher category. If the qualifications were awarded more than 15 years prior, the applicant is eligible for the Established Researcher category.
Applicants must hold a current position at an approved institution or organisation in Australia at the time of application; and must be an Australian citizen, a permanent resident currently residing in Australia, or a temporary resident currently residing in Australia and holding a JDRF research award.
Criteria
The Diabetes Research Innovation Awards seek to recognise research in the field of type 1 diabetes and its complications, demonstrating the highest innovation, influence and impact, published or patented in the 2011 calendar year.
All publications/patents are evaluated on the following criteria:
- Innovation in the approach to addressing a research question. Explanation of the innovative or unique aspect to the approach undertaken or methodology used to generate the research findings.
- Influence of the research findings in the field of research. Demonstrated evidence that these findings will change the understanding and direction of research in the area or improve the standard of practice.
- Impact of the research on the lives of people with type 1 diabetes, in the short or long-term. With particular reference to one or more of JDRF's therapeutic areas: Immune Therapies, Beta Cell Therapies, Complications Therapies or Glucose Control. Refer to the Australian Type 1 Diabetes Research Agenda.
The Awards are reviewed by a panel of eminent medical researchers in the field of type 1 diabetes and by a lay panel representing the type 1 diabetes community.
Applications
The 2012 Diabetes Research Innovation Awards will be open for applications from Friday, March 30th to Friday April 27th.
Applicants must submit:
- Completed Innovation Award application form;
- A two-page lay description of your publication/patent, with regard to the review criteria;
- A brief CV;
- A copy of your publication or proof of patent; and
- Two letters of support commenting on your publication/patent.
Applications are to be e-mailed as one document in MS Word or PDF format to mgfaward@jdrf.org.au no later than Friday April 27th.
Award winners should be prepared to discuss research achievements with the public and media.
This award will be opening soon.
For more information, contact JDRF by email at mgfaward@jdrf.org.au, or by phone on (02) 9020 6121.
Recipients of the 2011 Diabetes Research Innovation Award
The winners of the 2011 Diabetes Research Innovation Awards were announced at the annual scientific meeting of the Australian Diabetes Society.
Established Researcher
Dr David O'Neil
For his development of an educational algorithm that would be a tool to help people to respond in the best way to glucose information - both immediately and retrospectively.
Early Career Researcher
Helen Thomas PhD
For her work in understanding how insulin producing cells - known as beta cells - live and die.